CADLCandel Therapeutics, Inc.
$8.01+52% 1Y
$8.01
$4.4252 weeks$13.76
Latest close: below its 200-day averageOct 23, 2026what changed →
The financials
Candel Therapeutics, Inc. by the numbers
The next results filing is expected around Nov 12, 2026, the same week as a year ago.
| Income statement | Q2 2026 | Q2 2025 | Change |
|---|---|---|---|
| Operating income | −$27M | −$11M | n/a |
| Net income | −$39M | −$4.8M | n/a |
| Diluted EPS | −$0.52 | −$0.09 | n/a |